Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cardiac hypertrophy and oxidative stress: a leap of faith or stark reality?

Literature DB >> 11906997

Cardiac hypertrophy and oxidative stress: a leap of faith or stark reality?

D Lang.

Abstract

Entities: Disease

Mesh：

Substances：
Antioxidants
Nitric Oxide

Year: 2002 PMID： 11906997 PMCID： PMC1767053 DOI： 10.1136/heart.87.4.316

Source DB: PubMed Journal: Heart ISSN： 1355-6037 Impact factor: 5.994

× No keyword cloud information.

16 in total

1. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium.

Authors: T Ide; H Tsutsui; S Kinugawa; H Utsumi; D Kang; N Hattori; K Uchida; K i Arimura; K Egashira; A Takeshita
Journal: Circ Res Date: 1999-08-20 Impact factor: 17.367

Review 2. The roles of gender, the menopause and hormone replacement on cardiovascular function.

Authors: C S Hayward; R P Kelly; P Collins
Journal: Cardiovasc Res Date: 2000-04 Impact factor: 10.787

Review 3. Paracrine and autocrine effects of nitric oxide on myocardial function.

Authors: A M Shah; P A MacCarthy
Journal: Pharmacol Ther Date: 2000-04 Impact factor: 12.310

4. Coronary microvascular endothelial cell redox state in left ventricular hypertrophy : the role of angiotensin II.

Authors: D Lang; S I Mosfer; A Shakesby; F Donaldson; M J Lewis
Journal: Circ Res Date: 2000-03-03 Impact factor: 17.367

5. Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs.

Authors: J P Bell; S I Mosfer; D Lang; F Donaldson; M J Lewis
Journal: Am J Physiol Heart Circ Physiol Date: 2001-10 Impact factor: 4.733

6. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study.

Authors: R Lodi; B Rajagopalan; A M Blamire; J M Cooper; C H Davies; J L Bradley; P Styles; A H Schapira
Journal: Cardiovasc Res Date: 2001-10 Impact factor: 10.787

7. Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency.

Authors: S Gabsi; N Gouider-Khouja; S Belal; M Fki; M Kefi; I Turki; M Ben Hamida; H Kayden; R Mebazaa; F Hentati
Journal: Eur J Neurol Date: 2001-09 Impact factor: 6.089

8. 17beta-estradiol attenuates the development of pressure-overload hypertrophy.

Authors: M van Eickels; C Grohé; J P Cleutjens; B J Janssen; H J Wellens; P A Doevendans
Journal: Circulation Date: 2001-09-18 Impact factor: 29.690

9. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.

Authors: J D Luo; W W Zhang; G P Zhang; J X Guan; X Chen
Journal: Clin Exp Pharmacol Physiol Date: 1999-11 Impact factor: 2.557

10. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.

Authors: J T Peterson; H Hallak; L Johnson; H Li; P M O'Brien; D R Sliskovic; T M Bocan; M L Coker; T Etoh; F G Spinale
Journal: Circulation Date: 2001-05-08 Impact factor: 29.690

6 in total

Cardiac hypertrophy and oxidative stress: a leap of faith or stark reality?

1. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium.

Review 2. The roles of gender, the menopause and hormone replacement on cardiovascular function.

Review 3. Paracrine and autocrine effects of nitric oxide on myocardial function.

4. Coronary microvascular endothelial cell redox state in left ventricular hypertrophy : the role of angiotensin II.

5. Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs.

6. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study.

7. Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency.

8. 17beta-estradiol attenuates the development of pressure-overload hypertrophy.

9. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.

10. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.

Review 1. Mitochondrial SIRT3 and heart disease.

Review 2. Oxidative stress and heart disease: cardiac dysfunction, nutrition, and gene therapy.

3. Heme oxygenase-1 inhibits pro-oxidant induced hypertrophy in HL-1 cardiomyocytes.

Review 4. From sirtuin biology to human diseases: an update.

5. Mouse Sirt3 promotes autophagy in AngII-induced myocardial hypertrophy through the deacetylation of FoxO1.

Review 6. Molecular biomarkers in cardiac hypertrophy.